<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01552174</url>
  </required_header>
  <id_info>
    <org_study_id>MEIBUM survey</org_study_id>
    <nct_id>NCT01552174</nct_id>
  </id_info>
  <brief_title>Management of Eyelid Disorders by Ophthalmologists in Usual Medical Practice</brief_title>
  <acronym>MEIBUM</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Laboratoires Thea</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Iris Pharma</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Axial Biotech, Inc</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Laboratoires Thea</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the incidence and characteristics of eyelid
      inflammatory disorders during general ophthalmological consultations and to demonstrate
      association between palpebral pathologies and ocular surface pathologies.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">April 2014</completion_date>
  <primary_completion_date type="Actual">April 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of eyelid disorders in general ophthalmological practice</measure>
    <time_frame>Day 1</time_frame>
    <description>Systematic description of the eyelid, the ocular surface and the dermatological aspect of the face
Occurrence of Meibomian Gland Dysfunction(MGD).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Association between palpebral pathologies and ocular surface pathologies</measure>
    <time_frame>Day 1</time_frame>
    <description>To describe association between palpebral pathologies and ocular surface pathologies</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impact of eyelid disorder on patient's daily life</measure>
    <time_frame>Day 1</time_frame>
    <description>Consequences on vision, on daily life activities/work, on leisure, on contact lens wearing, on emotions, on sleeping,</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Current recommended strategy to treat eyelids disorders</measure>
    <time_frame>Day 1</time_frame>
    <description>Description of recommended strategy</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">185</enrollment>
  <condition>Palpebral Pathologies</condition>
  <condition>Ocular Surface Disease</condition>
  <condition>Meibomian Gland Dysfunction</condition>
  <arm_group>
    <arm_group_label>Outpatients attending general ophthalmologic consultation</arm_group_label>
    <description>Outpatients of either sex, aged at least 18 years, seen in general ophthalmological consultation
Patients informed of the objectives of the survey and agreeing to participate.
Patient attending to the ophthalmological consultation for any reasons: regular check-up of chronic disease, acute symptoms, or for surgery preparation or follow up.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients will be eligible for inclusion if all these criteria are respected:

          -  Outpatients of either sex, aged at least 18 years, seen in general ophthalmological
             consultation

          -  Patients informed of the objectives of the survey and agreeing to participate.

          -  Patient attending to the ophthalmological consultation for any reasons: regular
             check-up of chronic disease, acute symptoms, or for surgery preparation or follow up.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Outpatients of either sex, aged at least 18 years, seen in general ophthalmological
             consultation

          -  Patients informed of the objectives of the survey and agreeing to participate.

          -  Patient attending to the ophthalmological consultation for any reasons: regular
             check-up of chronic disease, acute symptoms, or for surgery preparation or follow up.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>José Manuel Benitez del Castillo, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>USIO, Departamento de Oftalmología, Hospital Clínico San Carlos, 28040 Madrid, Spain</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Consultation office</name>
      <address>
        <city>Heidelberg</city>
        <zip>69121</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>USIO Departamento de Oftalmologia Hospital Clínico San Carlos</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Spain</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 6, 2012</study_first_submitted>
  <study_first_submitted_qc>March 8, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 13, 2012</study_first_posted>
  <last_update_submitted>August 31, 2015</last_update_submitted>
  <last_update_submitted_qc>August 31, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 1, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>MGD</keyword>
  <keyword>ocular surface pathologies</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

